
Meera Natarajan
Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643 |
| Total Applications | 1062 |
| Issued Applications | 625 |
| Pending Applications | 87 |
| Abandoned Applications | 376 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5219218
[patent_doc_number] => 20070160529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Radioimmunoconjugates for targeted alpha therapy'
[patent_app_type] => utility
[patent_app_number] => 10/567813
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2622
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567813 | Radioimmunoconjugates for targeted alpha therapy | Jul 28, 2004 | Issued |
Array
(
[id] => 5112959
[patent_doc_number] => 20070196874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Method of examining colon cancer and colon adenoma'
[patent_app_type] => utility
[patent_app_number] => 10/568544
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3664
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568544 | Method of examining colon cancer and colon adenoma | Jul 8, 2004 | Issued |
Array
(
[id] => 366816
[patent_doc_number] => 07479546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-20
[patent_title] => 'Pro104 antibody compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/562259
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 71
[patent_no_of_words] => 57411
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/479/07479546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562259 | Pro104 antibody compositions and methods of use | Jun 27, 2004 | Issued |
Array
(
[id] => 352780
[patent_doc_number] => 07491802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer'
[patent_app_type] => utility
[patent_app_number] => 10/558567
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 9142
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558567 | Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer | May 26, 2004 | Issued |
Array
(
[id] => 5112451
[patent_doc_number] => 20070196366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Methods for treating cancer using an immunotoxin'
[patent_app_type] => utility
[patent_app_number] => 10/554788
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30088
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554788 | Methods for treating cancer using an immunotoxin | Apr 29, 2004 | Abandoned |
Array
(
[id] => 5241780
[patent_doc_number] => 20070020272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/554814
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13454
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554814 | Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof | Apr 29, 2004 | Abandoned |
Array
(
[id] => 22778
[patent_doc_number] => 07799899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Compositions and methods relating to STOP-1'
[patent_app_type] => utility
[patent_app_number] => 10/553491
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 112
[patent_no_of_words] => 58936
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553491 | Compositions and methods relating to STOP-1 | Apr 15, 2004 | Issued |
Array
(
[id] => 5051354
[patent_doc_number] => 20070031899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Drug'
[patent_app_type] => utility
[patent_app_number] => 10/551866
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14074
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551866 | Pharmaceutical agents | Apr 4, 2004 | Issued |
Array
(
[id] => 7181188
[patent_doc_number] => 20040202646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy'
[patent_app_type] => new
[patent_app_number] => 10/815925
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10948
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20040202646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815925
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815925 | Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy | Apr 1, 2004 | Issued |
Array
(
[id] => 7383328
[patent_doc_number] => 20040180002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => new
[patent_app_number] => 10/810163
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6757
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810163
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810163 | Cancerous disease modifying antibodies | Mar 25, 2004 | Issued |
Array
(
[id] => 7159394
[patent_doc_number] => 20050084449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/805177
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 30423
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10805177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/805177 | Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof | Mar 18, 2004 | Issued |
Array
(
[id] => 5630990
[patent_doc_number] => 20060147458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/547207
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547207 | Vaccines | Feb 25, 2004 | Abandoned |
Array
(
[id] => 169821
[patent_doc_number] => 07662387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders'
[patent_app_type] => utility
[patent_app_number] => 10/546304
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 39087
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546304 | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders | Feb 19, 2004 | Issued |
Array
(
[id] => 4995229
[patent_doc_number] => 20070010574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Use of a trpm8-activating substance for the treatment of tumours'
[patent_app_type] => utility
[patent_app_number] => 10/539874
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 2825
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010574.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539874 | Use of a trpm8-activating substance for the treatment of tumours | Dec 15, 2003 | Pending |
Array
(
[id] => 795466
[patent_doc_number] => 07429380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Production of a multimeric protein by cell fusion method'
[patent_app_type] => utility
[patent_app_number] => 10/719006
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8065
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719006 | Production of a multimeric protein by cell fusion method | Nov 19, 2003 | Issued |
Array
(
[id] => 318833
[patent_doc_number] => 07521543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => 'A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same'
[patent_app_type] => utility
[patent_app_number] => 10/532489
[patent_app_country] => US
[patent_app_date] => 2003-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 11366
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532489 | A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same | Oct 22, 2003 | Issued |
Array
(
[id] => 5732753
[patent_doc_number] => 20060257870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Cdkl 1 as modifier of branching morphogenesis and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/532405
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16623
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532405 | Cdkl 1 as modifier of branching morphogenesis and methods of use | Oct 21, 2003 | Abandoned |
Array
(
[id] => 5843075
[patent_doc_number] => 20060121476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Cancer associated antigens, sga-56m and sga-56mv, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/527572
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 50922
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527572 | Cancer associated antigens, sga-56m and sga-56mv, and uses thereof | Sep 11, 2003 | Abandoned |
Array
(
[id] => 22769
[patent_doc_number] => 07794711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Agent for treating chondroma and chondrosarcoma'
[patent_app_type] => utility
[patent_app_number] => 10/533584
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24559
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/794/07794711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533584 | Agent for treating chondroma and chondrosarcoma | Aug 21, 2003 | Issued |
Array
(
[id] => 74277
[patent_doc_number] => 07749962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Alpha 5 beta 1 and its ability to regulate the cell survival pathway'
[patent_app_type] => utility
[patent_app_number] => 10/521841
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13149
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521841 | Alpha 5 beta 1 and its ability to regulate the cell survival pathway | Jul 15, 2003 | Issued |